K. Mayo

Outcomes of dalteparin use following total knee arthroplasty: a retrospective analysis

S. Wagner, Jeffrey D. Miller, M. Russell, 2002, Expert review of pharmacoeconomics & outcomes research.

Novel Simulation Model of Non-Muscle Invasive Bladder Cancer: A Platform for a Virtual Randomized Trial of Conservative Therapy vs. Cystectomy in BCG Refractory Patients

W. Sexton, P. Clark, G. Steinberg, 2015, Bladder Cancer.

Novel Simulation Model of Non-Muscle Invasive Bladder Cancer: A Platform for a Virtual Randomized Trial of Conservative Therapy vs. Cystectomy in BCG Refractory Patients.

W. Sexton, P. Clark, G. Steinberg, 2012, Bladder cancer.

Health outcomes evaluations: estimating the impact of almotriptan in managed care settings.

J. Osterhaus, K. Mayo, 2002, The American journal of managed care.

Outcomes of dalteparin use following total knee arthroplasty: a retrospective analysis

S. Wagner, Jeffrey D. Miller, M. Russell, 2002, Expert review of pharmacoeconomics & outcomes research.

Low-Molecular-Weight Heparin Therapy for Patients Undergoing Total Knee Replacement Surgery: Cost and Outcomes

E. Mozaffari, L. Allen, K. Mayo, 2003 .